Gain Therapeutics, Inc. (GANX) Financials
GANX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 14.1 million | 6.8 million |
2023-06-30 | 18.3 million | 7.2 million |
2023-03-31 | 21.3 million | 6.2 million |
2022-12-31 | 24.1 million | 5.2 million |
GANX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -4.0 million | 907327 |
2023-06-30 | -5.0 million | 1.2 million |
2023-03-31 | -4.2 million | 565432 |
2022-12-31 | -3.9 million | 558692 |
GANX Net Income
No data available :(
GANX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 12.2 million | - | 494624 |
2023-06-30 | 16.2 million | 466638 | 565869 |
2023-03-31 | 17.8 million | 478296 | 618429 |
2022-12-31 | 20.1 million | 495258 | 670864 |
GANX Shares Outstanding
GANX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 650 | 2.4 million | 2.5 million | - |
2023-06-30 | 3644 | 4.0 million | 3.7 million | - |
2023-03-31 | 11045 | 2.8 million | 2.5 million | - |
2022-12-31 | 9398 | 2.3 million | 2.3 million | - |
GANX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 20509 |
2023-06-30 | - | 20239 |
2023-03-31 | 55180 | 19242 |
2022-12-31 | 140108 | 18110 |
GANX
Price: $2.91
52 week price:
Earnings Per Share: -1.71 USD
P/E Ratio: -2.65
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 17900
Market Capitalization: 48.0 million